Compare Becton Dickinson and Co (BDX) vs Fox Corp Class B (FOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Fox Corp Class B — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $49.41B), while Fox Corp Class B trades at $55.42 (market cap $24.58B). The key difference: Becton Dickinson and Co is far larger — about 2× Fox Corp Class B's market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | FOX | |
|---|---|---|
Market Cap | $49.41B | $24.58B |
Sector | Health | Media |
52-Week High | $185.39 | $67.76 |
52-Week Low | $138.62 | $44.39 |
Enterprise Value | $65.51B | $27.94B |
Dividend Yield | 2.32% | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $183.71, up 2.27% today, near its consensus price target of $183.00. The stock shows bullish technical signals with strong moving averages, though RSI indicates overbought conditions. Fundamentally, revenue grew to $21.84 billion in 2025, with consistent earnings beats in recent quarters, including Q3 2026 EPS of $3.23 beating estimates. The company maintains a dividend of $1.05 per share and recently raised full-year guidance, reflecting operational strength amid tariff pressures.
Outlook remains positive with raised profit guidance and segment growth, but risks include margin pressure from tariffs and a product recall. Analyst sentiment is mixed with 47% buy ratings, suggesting cautious optimism. The stock offers stability as a Dividend Aristocrat with growth catalysts from medical technology advancements, though investors should monitor margin trends and competitive dynamics.
FOX Corp trades at $55.99, down 0.6% with bullish technical signals and strong fundamental performance. The company reported robust Q2 2026 earnings of $1.79 EPS, beating expectations by 24%, with revenue growth accelerating to $16.3B in 2025. Analyst sentiment remains mixed with 43% buy ratings, while technical indicators show support at $54-55 levels with moving averages trending upward.
Outlook remains positive with digital growth momentum from Tubi and FOX One driving advertising revenue. Key risks include advertising market volatility and competitive pressures. The stock presents value opportunity with reasonable P/E of 14.4x and strong cash flow generation, though investors should monitor Q3 2026 earnings delivery against $2 EPS expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →
